Advertisement
AXON vs CYPH
Which Stock Would AI Choose? Axon Enterprise (AXON) vs. Cypherpunk Technologies (CYPH) Stock Comparison
Key Takeaways
- AXON is a large-cap public safety technology leader with strong recurring revenue growth, while CYPH is a small-cap digital asset treasury company tied to the volatile price of Zcash (ZEC).
- Axon's shares have rebounded in recent weeks after a sharp year-to-date decline, whereas Cypherpunk's shares have delivered outsized gains but with extreme volatility.
- The two companies operate in fundamentally different sectors — aerospace and defense versus crypto/blockchain — making this comparison one of contrasting risk profiles rather than direct business overlap.
- Axon enjoys broad analyst coverage and a consensus "Buy" rating; Cypherpunk trades with limited revenue and earnings heavily driven by mark-to-market (asset revaluation) swings in its Zcash holdings.
- Both names carry notable risks: Axon's valuation and government-budget dependence, and Cypherpunk's concentration in a single digital asset and Nasdaq listing-compliance history.
- For deeper detail on each name, explore AXON Major News and AXON Today's Price Move, as well as CYPH Major News and CYPH Today's Price Move.
- To see how AI evaluates opportunities like these in real time, explore Trending AI Robots.
Introduction
Comparing AXON and CYPH is less a like-for-like rivalry than a study in contrasting market positioning. Axon Enterprise is an established, large-cap provider of public safety hardware and software, while Cypherpunk Technologies is a small-cap privacy technology and digital asset treasury company. They appeal to very different investors: Axon to those seeking long-term recurring revenue growth in a defensible niche, and Cypherpunk to those willing to accept crypto-driven volatility for higher-risk, higher-reward exposure. This stock comparison examines relative performance, business models, growth drivers, and risk factors to help readers understand where each name stands in the current market environment.
AXON Overview and Recent Performance
Axon Enterprise is a global public safety technology company best known for TASER conducted energy weapons and body-worn cameras, now paired with a growing software ecosystem that includes Axon Evidence, Draft One, Axon Records, and Fusus, plus counter-drone capabilities through its Dedrone unit. The company has been shifting customers toward premium software and AI-enabled bundles, driving annual recurring revenue to roughly $1.6 billion with net revenue retention around 126% and future contracted bookings reported near $15.1 billion.
In recent weeks, Axon has generated fresh momentum after a difficult stretch. The launch of its next-generation Axon Body 5 camera — positioned as built for the AI era with substantially more on-device processing power — contributed to a multi-day winning streak. Still, the stock remains well below its 52-week high, with the year-to-date return deep in negative territory despite strong top-line growth. Analysts broadly maintain a "Buy" consensus, though several firms have trimmed price targets, reflecting a balance between durable demand and concerns about valuation, profitability margins, and reliance on government budgets.
CYPH Overview and Recent Performance
Cypherpunk Technologies, formerly Leap Therapeutics, describes itself as a privacy technology company. Its primary strategy is a digital asset treasury centered on accumulating Zcash (ZEC), a privacy-focused cryptocurrency, with a stated ambition to hold a meaningful share of the coin's circulating supply. Through its Leap Therapeutics subsidiary, the company also continues developing cancer therapies, including sirexatamab for colorectal cancer.
Cypherpunk's recent market activity has been exceptionally volatile. The stock has posted outsized gains over the trailing year, moving from well below one dollar to a range of roughly $3 to $4, while its 52-week span is wide enough to underscore significant swings. This performance is closely tied to Zcash's price, because the company's financial results are marked to market each quarter — a sharp decline in ZEC contributed to a substantial net loss in its most recently reported quarter. With limited operating revenue, a concentrated shareholder base led by Winklevoss Capital, and a prior Nasdaq minimum bid price compliance notice, Cypherpunk represents a high-beta, catalyst-sensitive profile.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of the platform's AI trading bots. Tickeron offers hundreds of AI trading bots that collectively trade thousands of different tickers, but only those best suited to current market conditions earn a place in this featured section. Each bot operates with its own trading style, strategy, timeframe, performance history, and statistical profile, and each targets a distinct set of tickers — from large-cap momentum names to small-cap and volatile instruments. This diversity allows users to scan for approaches that align with different risk appetites, whether they favor the steadier trend characteristics of a company like Axon or the higher-volatility behavior of a name like Cypherpunk. To review the currently featured strategies and their performance data, visit Trending AI Robots.
Head-to-Head Comparison
The clearest contrast between these two names is scale and business maturity. AXON generates billions in revenue, has a large market capitalization, and enjoys deep analyst coverage and a visible path to recurring software revenue. CYPH, by contrast, has a market capitalization under roughly half a billion dollars and minimal operating revenue, with results driven almost entirely by the fair value of its Zcash treasury.
Their growth drivers also differ sharply. Axon's momentum comes from contract bookings, hardware upgrade cycles, international expansion, and AI software adoption — factors that are relatively predictable but sensitive to public-sector spending. Cypherpunk's fortunes hinge on cryptocurrency market dynamics, Zcash's adoption, and broader sentiment toward privacy assets, which introduces far greater swings in both earnings and share price.
Risk profiles diverge as well. Axon carries a premium valuation and margin pressure from newer hardware and counter-drone offerings, alongside dependence on government budgets. Cypherpunk carries concentration risk in a single digital asset, custody and related-party arrangements, listing-compliance history, and limited liquidity runway. In sector exposure and market sentiment, Axon trades as a growth-oriented industrial/defense name, while Cypherpunk behaves more like a leveraged crypto proxy.
Tickeron AI Verdict
Based on observable factors such as trend consistency, stability, and relative positioning, Tickeron's AI would likely favor AXON for its more consistent underlying trend, recurring revenue base, and breadth of institutional coverage, even amid a recent drawdown. Cypherpunk's (CYPH) momentum is strong but structurally volatile and closely coupled to a single asset's price, which typically signals less stability in automated trend analysis. That said, the verdict is probabilistic rather than absolute: momentum-oriented strategies may still find Cypherpunk's volatility attractive under the right conditions. The preferred choice ultimately depends on the strategy, timeframe, and risk tolerance built into each individual bot's logic.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and CYPH is a Hold.
AXON in upward trend: price may jump up because it broke its lower Bollinger Band on November 06, 2026
AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 33 cases where AXON's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 273 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXON as a result. In 55 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.
The Moving Average Convergence Divergence Histogram (MACD) for AXON turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 30 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
The 50-day moving average for AXON moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 66 (best 1 - 100 worst), indicating fairly steady price growth. AXON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.920) is normal, around the industry mean (5.050). AXON has a moderately high P/E Ratio (126.721) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.367).
CYPH sees MACD Histogram just turned negative
CYPH saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 38 instances where the indicator turned negative. In 36 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CYPH as a result. In 66 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
CYPH moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CYPH crossed bearishly below the 50-day moving average on November 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CYPH entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +21.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYPH advanced for three days, in 216 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. CYPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.228) is normal, around the industry mean (2.412). P/E Ratio (4.500) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.270) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (15.694).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
AXON | CYPH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 54 | 23 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 83 | 100 | |
SMR RATING 1..100 | 81 | 91 | |
PRICE GROWTH RATING 1..100 | 66 | 34 | |
P/E GROWTH RATING 1..100 | 80 | 92 | |
SEASONALITY SCORE 1..100 | 30 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AXON's Valuation (90) in the Biotechnology industry is in the same range as CYPH (100). This means that AXON’s stock grew similarly to CYPH’s over the last 12 months.
AXON's Profit vs Risk Rating (83) in the Biotechnology industry is in the same range as CYPH (100). This means that AXON’s stock grew similarly to CYPH’s over the last 12 months.
AXON's SMR Rating (81) in the Biotechnology industry is in the same range as CYPH (91). This means that AXON’s stock grew similarly to CYPH’s over the last 12 months.
CYPH's Price Growth Rating (34) in the Biotechnology industry is in the same range as AXON (66). This means that CYPH’s stock grew similarly to AXON’s over the last 12 months.
AXON's P/E Growth Rating (80) in the Biotechnology industry is in the same range as CYPH (92). This means that AXON’s stock grew similarly to CYPH’s over the last 12 months.
| AXON | CYPH | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 76% | N/A |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 80% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 88% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 69% | 2 days ago 89% |
| TrendMonth ODDS (%) | 2 days ago 71% | 2 days ago 89% |
| Advances ODDS (%) | 16 days ago 74% | 8 days ago 89% |
| Declines ODDS (%) | 2 days ago 70% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 79% | N/A |
| Aroon ODDS (%) | 2 days ago 83% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXON’s FA Score shows that 0 FA rating(s) are green while CYPH’s FA Score has 0 green FA rating(s).
- AXON’s FA Score: 0 green, 5 red.
- CYPH’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXON’s TA Score shows that 4 TA indicator(s) are bullish while CYPH’s TA Score has 2 bullish TA indicator(s).
- AXON’s TA Score: 4 bullish, 5 bearish.
- CYPH’s TA Score: 2 bullish, 6 bearish.
Price Growth
AXON (@Aerospace & Defense) experienced а -27.37% price change this week, while CYPH (@Investment Managers) price change was -18.08% for the same time period.
The average weekly price growth across all stocks in the @Aerospace & Defense industry was +5.10%. For the same industry, the average monthly price growth was -0.96%, and the average quarterly price growth was -12.76%.
The average weekly price growth across all stocks in the @Investment Managers industry was -2.64%. For the same industry, the average monthly price growth was -2.86%, and the average quarterly price growth was -1.76%.
Reported Earning Dates
AXON is expected to report earnings on Mar 02, 2027.
CYPH is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Aerospace & Defense (+5.10% weekly)Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.
@Investment Managers (-2.64% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FDTS | 66.71 | 0.06 | +0.09% |
| First Trust Developed Markets ex-US Small Cap AlphaDEX Fund (FDTS) | |||
| FRI | 31.56 | -0.05 | -0.16% |
| First Trust S&P REIT Index Fund (FRI) | |||
| PSFD | 40.75 | -0.07 | -0.16% |
| Pacer Swan SOS Flex (January) ETF (PSFD) | |||
| OEF | 369.09 | -2.12 | -0.57% |
| iShares S&P 100 ETF (OEF) | |||
| SLVP | 31.76 | -1.86 | -5.53% |
| iShares MSCI Global Silver Miners ETF (SLVP) | |||